Related Articles
Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin
Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADMÂ cells by downregulating P-gp and MRP-1 Corrigendum in /10.3892/ijmm.2023.5315
Osthole shows the potential to overcome P-glycoprotein‑mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway
Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway